Cargando…

Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19

Detalles Bibliográficos
Autores principales: Zheng, Qian, Ma, Pengfei, Feng, Zhanhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771576/
https://www.ncbi.nlm.nih.gov/pubmed/36577594
http://dx.doi.org/10.1016/j.ajem.2022.12.027
_version_ 1784854840982110208
author Zheng, Qian
Ma, Pengfei
Feng, Zhanhui
author_facet Zheng, Qian
Ma, Pengfei
Feng, Zhanhui
author_sort Zheng, Qian
collection PubMed
description
format Online
Article
Text
id pubmed-9771576
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-97715762022-12-22 Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19 Zheng, Qian Ma, Pengfei Feng, Zhanhui Am J Emerg Med Article Elsevier Inc. 2023-03 2022-12-22 /pmc/articles/PMC9771576/ /pubmed/36577594 http://dx.doi.org/10.1016/j.ajem.2022.12.027 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zheng, Qian
Ma, Pengfei
Feng, Zhanhui
Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19
title Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19
title_full Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19
title_fullStr Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19
title_full_unstemmed Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19
title_short Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19
title_sort acute pulmonary emboli following rebound phenomenon after nirmatrelvir/ritonavir treatment for covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771576/
https://www.ncbi.nlm.nih.gov/pubmed/36577594
http://dx.doi.org/10.1016/j.ajem.2022.12.027
work_keys_str_mv AT zhengqian acutepulmonaryembolifollowingreboundphenomenonafternirmatrelvirritonavirtreatmentforcovid19
AT mapengfei acutepulmonaryembolifollowingreboundphenomenonafternirmatrelvirritonavirtreatmentforcovid19
AT fengzhanhui acutepulmonaryembolifollowingreboundphenomenonafternirmatrelvirritonavirtreatmentforcovid19